Skip to content

Clinical trials

Phase 2 Renal Insufficiency, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 2 Country / region: Germany Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20062
20082
20091
20104
20124
20134
20143
20151
20161
20173
20181
20203
20213
20223
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
Boehringer Ingelheim5
GlaxoSmithKline5
AstraZeneca3
Novartis Pharmaceuticals3
Relypsa, Inc.2
AMAG Pharmaceuticals, Inc.1
Abbott1
Amgen1
Armin Goralczyk1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic40
Anemia11
Diabetes Mellitus, Type 24
Diabetic Nephropathies4
Hyperphosphatemia4
Kidney Failure, Chronic4
Hyperkalemia3
Heart Failure2
Renal Insufficiency2
Acute Kidney Injury1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.